[an error occurred while processing this directive]

Research progress of myosin heavy chain genes in human genetic diseases

Expand
  • Medical Genetics Lab, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Received date: 2017-03-16

  Revised date: 2017-07-25

  Online published: 2017-08-07

Supported by

the National Natural Science Foundation of China(31571295)

Abstract

Myosins constitute a large superfamily proteins, which convert chemical energy, through ATP hydrolysis, to mechanical force for diverse cellular movements, such as cell migration and muscle contraction. The class Ⅱ myosin forms the filaments in muscle and non-muscle cells as a hexameric protein complex, consisting of two myosin heavy chain (MyHC) subunits and two pairs of non-identical light chain subunits. There are several MyHC isoforms encoded by different genes of the MYH family in humans. At present, distinct mutations in different genes of the MYH family are associated with various human genetic diseases. Mutations in MYH2 are associated with skeletal myopathies, characterized by ophthalmoplegia. Mutations in MYH3 and MYH8 are associated with distal arthrogryposis syndromes. Mutations in MYH7 are associated with not only skeletal muscle diseases, such as Laing distal myopathy and myosin storage myopathy, but also hypertrophic cardiomyopathy. Mutations in MYH9 are associated with the so-called MYH9-related disease, characterized by giant platelets, thrombocytopenia and granulocyte inclusions. In this review, we briefly discuss the expression patterns of the MYH gene family and summarize the research progress in correlating the abnormalities of MYH gene family with various human genetic diseases.

Cite this article

Yimin He, Mingmin Gu . Research progress of myosin heavy chain genes in human genetic diseases[J]. Hereditas(Beijing), 2017 , 39(10) : 877 -887 . DOI: 10.16288/j.yczz.17-090

References

[1] Foth BJ, Goedecke MC, Soldati D. New insights into myosin evolution and classification. Proc Natl Acad Sci USA, 2006, 103(10): 3681-3686.
[2] Sellers JR. Myosins: a diverse superfamily. Biochim Biophys Acta, 2000, 1496(1): 3-22.
[3] Clark KA, McElhinny AS, Beckerle MC, Gregorio CC. Striated muscle cytoarchitecture: an intricate web of form and function. Annu Rev Cell Dev Biol, 2002, 18: 637-706.
[4] Willis T, Hedberg-Oldfors C, Alhaswani Z, Kulshrestha R, Sewry C, Oldfors A. A novel.MYH2 mutation in family members presenting with congenital myopathy, ophthalmoplegia and facial weakness. J Neurol, 2016, 263(7): 1427-1433.
[5] Colegrave M, Peckham M. Structural implications of β-cardiac myosin heavy chain mutations in human disease. Anat Rec (Hoboken), 2014, 297(9): 1670-1680.
[6] Eichel Y, Tormos LM, Squires JE. Preoperative use of platelets in a 6-year-old with acute appendicitis and a myosin heavy chain 9-related disorder: a case report and review of literature. Transfusion, 2016, 56(2): 349-353.
[7] Schiaffino S, Reggiani C. Fiber types in mammalian skeletal muscles. Physiol Rev, 2011, 91(4): 1447-1531.
[8] Pedrosa-Domell?f F, Holmgren Y, Lucas CA, Hoh JFY, Thornell LE. Human extraocular muscles: unique pattern of myosin heavy chain expression during myotube formation. Invest Ophthalmol Vis Sci, 2000, 41(7): 1608-1616.
[9] Oldfors A. Hereditary myosin myopathies. Neuromuscul Disord, 2007, 17(5): 355-367.
[10] Newell-Litwa KA, Horwitz R, Lamers ML. Non-muscle myosin II in disease: mechanisms and therapeutic opportunities. Dis Model Mech, 2015, 8(12): 1495-1515.
[11] Toydemir RM, Rutherford A, Whitby FG, Jorde LB, Carey JC, Bamshad MJ. Mutations in embryonic myosin heavy chain (MYH3) cause Freeman-Sheldon syndrome and Sheldon-Hall syndrome. Nat Genet, 2006, 38(5): 561-565.
[12] Chong JX, Burrage LC, Beck AE, Marvin CT, McMillin MJ, Shively KM, Harrell TM, Buckingham KJ, Bacino CA, Jain M, Alanay Y, Berry SA, Carey JC, Gibbs RA, Lee BH, Krakow D, Shendure J, Nickerson DA, University of Washington Center for Mendelian Genomics, Bamshad MJ. Autosomal-dominant multiple pterygium syndrome is caused by mutations in MYH3. Am J Hum Genet, 2015, 96(5): 841-849.
[13] Posch MG, Waldmuller S, Müller M, Scheffold T, Fournier D, Andrade-Navarro MA, De Geeter B, Guillaumont S, Dauphin C, Yousseff D, Schmitt KR, Perrot A, Berger F, Hetzer R, Bouvagnet P, ?zcelik C. Cardiac alpha-myosin (MYH6) is the predominant sarcomeric disease gene for familial atrial septal defects. PLoS One, 2011, 6(12): e28872.
[14]
Outlines

/